Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MANUEL GUZMAN

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1891835427
CMS profile
388440
Location
SAN JUAN, PR

General Payments · PY2018–2024

$247,593.33

  • Reported across 321 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$9,217.18

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $9,069.42 7
Janssen Biotech, Inc. $93.54 1
Acerta Pharma LLC $54.22 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $45,300.59 65
PY2019 $60,297.73 72
PY2020 $31,367.19 40
PY2021 $37,589.07 65
PY2022 $43,009.12 44
PY2023 $20,812.45 24
PY2024 $9,217.18 11

Payment records · PY2024 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $17.36 02/28/2024 Food and Beverage Undisputed 01/23/2026 1104397539 CMS
AstraZeneca Pharmaceuticals LP $17.60 04/24/2024 Food and Beverage Undisputed 01/23/2026 1104201045 CMS
AstraZeneca Pharmaceuticals LP $19.26 09/23/2024 Food and Beverage Undisputed 01/23/2026 1104538250 CMS
Janssen Biotech, Inc. $93.54 11/12/2024 Food and Beverage Undisputed 01/23/2026 1078614958 CMS
Janssen Pharmaceuticals, Inc $1,030.00 03/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078172083 CMS
Janssen Pharmaceuticals, Inc $1,030.00 03/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078172197 CMS
Janssen Pharmaceuticals, Inc $78.87 08/01/2024 Food and Beverage Undisputed 01/23/2026 1078172219 CMS
Janssen Pharmaceuticals, Inc $52.55 08/02/2024 Food and Beverage Undisputed 01/23/2026 1078170321 CMS
Janssen Pharmaceuticals, Inc $80.00 09/16/2024 Food and Beverage Undisputed 01/23/2026 1078172221 CMS
Janssen Pharmaceuticals, Inc $3,399.00 09/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078172203 CMS
Janssen Pharmaceuticals, Inc $3,399.00 09/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078172215 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.